Opko Health, Inc. Expected To Post A Loss Of 7 Cents A Share: Earnings Preview

OPKO Health

Yesterday 21:39

OPKO Health, Inc. OPK.OQ OPK.O is expected to  show a fall in quarterly revenue when it reports  results on October 27 (estimated) for the period ending September 30 2026
The Miami Florida-based  company is expected to report a 6.9% decrease in revenue to $141.267 million from $151.7 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on July 27 2026, for the period ended September 30, was for revenue between $131.00 million and $142.00 million.
​LSEG's mean analyst estimate for OPKO Health, Inc. is for a loss of 7 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for OPKO Health, Inc. is $3.00, about 84% above its last closing price of $1.63
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Jun. 30 2026
-0.08
-0.08
-0.01
Beat
87.5
Mar. 31 2026
-0.06
-0.07
-0.07
Met
0
Dec. 31 2025
-0.07
-0.07
-0.04
Beat
41.7​
Sep. 30 2025
-0.04
-0.04
0.03
Beat
166.7
​​Jun. 30 2025
-0.10
-0.11
-0.19
Missed
-67.7
Mar. 31 2025
-0.06
-0.07
-0.10
Missed
-45.8​
Dec. 31 2024
-0.10
-0.09
0.01
Beat
110.7
Sep. 30 2024
-0.09
-0.09
-0.09
Met
3.6
This summary was machine generated October 23 at 20:39 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)